Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors clinical trials

Explore recruiting advanced unresectable or metastatic human epidermal growth receptor 2 her2 expressing her2 mutated solid tumors clinical trials.

Also recruiting in Europe

Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Master rollover study to provide continued access to, and assess, long term safety of the study drugs.

France, Spain, Belgium, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

DS-1103a Combination Therapy First-in-human (FIH) Study

Spain, France, Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors trials by city

Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Toronto Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Vancouver Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Montreal Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Calgary Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Edmonton Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Ottawa Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Winnipeg Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Quebec City Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Hamilton Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Kitchener Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in London Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Halifax Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in New York Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Los Angeles Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Chicago Advanced Unresectable Or Metastatic Human Epidermal Growth Receptor 2 Her2 Expressing Her2 Mutated Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease